![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Pro-Pharmaceuticals, Medidata to Implement EDC in Phase II Trial
Pro-Pharmaceuticals, Medidata to Implement EDC in Phase II Trial
Medidata Solutions, a global electronic clinical data management solutions provider, will provide Pro-Pharmaceuticals, a developer of novel carbohydrate compounds that enable the targeted delivery of chemotherapy drugs to cancer cells, with state-of-the-art electronic data capture technology for Pro-Pharmaceuticals' Phase II clinical trial.
Pro-Pharmaceuticals has initiated a Phase II clinical trial to evaluate efficacy and safety of Davanat/5-FU when administered in monthly cycles as a third-line therapy for metastatic colorectal cancer.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
11Jul
-
18Jul
-
21Oct